Delivery Order SPE2DB20D1004-SPE2DB23FF5P6
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,943.82, is for the supply of Zolmitriptan 2.5 mg Orally Disintegrating Tablets (ODT) on a firm-fixed-price basis. The contract has an ultimate completion date of February 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,903.13, is for the delivery of Zolmitriptan 2.5 mg tablets to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award, with a ceiling value of $1,030.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of zolmitriptan 5 mg orally disintegrating tablets, a medication used to treat migraines. The award has an ultimate completion date of June 4, 2024 and is a Firm Fixed Price contract. This contract award is not designated as a set-aside and is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,401.73 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg tablets to support military healthcare programs. The award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.51 firm fixed-price delivery order is for the supply of 4566777776 units of the medication zolmitriptan 5 mg tablets, with an ultimate completion date of December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, SPE2DB20D3103|SPE2DB24FP9T2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,032.27 firm fixed-price delivery order is for the supply of zolmitriptan 2.5 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2024. It is not designated as a set-aside contract....
- The Defense Logistics Agency awarded a $1,281.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). The contract is non-set-aside and competitively awarded, with a completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which falls...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of pharmaceutical products. Specifically, the contract is for the supply of Zolmitriptan 5 mg orally disintegrating tablets. The contract has a ceiling value of $1,072.07 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,465.79, is for the delivery of zolmitriptan 2.5 mg orally disintegrating tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets. The $3,628.18 firm fixed price contract has a completion date of May 1, 2023 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF5P6Delivery Order
This federal contract award, valued at $1,779.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 5 mg Orally Disintegrating Tablets, a prescription medication used to treat migraines. This is a firm-fixed-price delivery order contract with a completion date of March 31, 2023. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 3/30/23 |